The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic chimeric antigen receptor T-cell ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

Xilio Therapeutics Inc. has announced three wholly owned preclinical programs for masked T-cell engagers targeting prostate-specific membrane antigen (PSMA), claudin 18.2 (CLDN18.2) and ...

Bristol Myers Squibb (BMS) has reported that the multi-centre Phase II TRANSCEND FL trial assessing its cluster of ...

Trenchant partnered with Autolomous, integrating its digital solution into its CGT manufacturing platform, for faster production and lower costs.

Neurons are cells in the body that are responsible for transmitting electrical ... The motor neurons work with your muscles to move the body in a series of movements that you don't typically even ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and fight cancer more effectively. They identified flaws in traditional methods, ...